Loading...
Please wait, while we are loading the content...
Similar Documents
Nicotinamide and phosphate homeostasis in chronic kidney disease
| Content Provider | Scilit |
|---|---|
| Author | Ginsberg, Charles Ix, Joachim H. |
| Copyright Year | 2016 |
| Description | Journal: Current opinion in nephrology and hypertension Purpose of review Higher serum phosphate concentration is a central driver of the chronic kidney disease (CKD) mineral bone disorder (MBD). Although phosphate binders are commonly used to lower phosphate, they are minimally effective in CKD. Nicotinamide (vitamin B3) decreases intestinal phosphate transport in animals. Its efficacy and safety in CKD is uncertain. Recent findings We review data differentiating nicotinamide from nicotinic acid (niacin) and compare the metabolism and side-effect profile of each. Several recent studies have tested the safety and efficacy of nicotinamide in patients with CKD and the general population. Available data on efficacy and safety, gaps in knowledge, and ongoing studies to address them are described. Summary Nicotinamide is a novel potential tool to treat hyperphosphatemia in patients with CKD, but additional data on safety and efficacy are required before widespread clinical use. |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082387/pdf |
| Ending Page | 291 |
| Page Count | 7 |
| Starting Page | 285 |
| ISSN | 10624821 |
| e-ISSN | 14736543 |
| DOI | 10.1097/mnh.0000000000000236 |
| Journal | Current opinion in nephrology and hypertension |
| Issue Number | 4 |
| Volume Number | 25 |
| Language | English |
| Publisher | Ovid Technologies (Wolters Kluwer Health) |
| Publisher Date | 2016-07-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: Current opinion in nephrology and hypertension Urology and Nephrology Mineral Bone Disorder |
| Content Type | Text |
| Resource Type | Article |
| Subject | Internal Medicine Nephrology |
